Ocera Therapeutics Receives $20,000,000 New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dcc2f09e-e1fa-469e-b36b-309b809b2be0
Date
8/3/2015
Company Name
Ocera Therapeutics
Mailing Address
525 University Avenue Palo Alto, CA 94301 USA
Company Description
Ocera Therapeutics Inc. founded in January 2005, is a privately held, clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for gastrointestinal and liver diseases.
Website
http://www.ocerainc.com
Transaction Type
Debt
Transaction Amount
$20,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Ocera intends to use the capital to support development of its OCR-002 molecule to treat acute and chronic patients with hepatic encephalopathy.
M&A Terms
Venture Investor
Oxford Finance
Venture Investor
Silicon Valley Bank